Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM Gertie Chimeka Anyanwoke 14 Jan 2021 19:54 CST

https://www.nejm.org/doi/full/10.1056/NEJMoa2034201

Sent from my iPhone